Foster Nexthaler

Foster is a pharmaceutical product primarily used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains a fixed-dose combination of beclometasone dipropionate and formoterol fumarate dihydrate. This specific version, the 'Nexthaler', is a dry powder inhaler designed to deliver medicine deep into the lungs through a breath-actuated device.

The brand originated in Italy, developed by Chiesi Farmaceutici, a family-owned pharmaceutical group founded in Parma in 1935. Today, Chiesi remains an independent international group with a strong commitment to respiratory health and research. The manufacturing for this product typically occurs in Italy, specifically in their advanced facilities located in the Parma region, ensuring strict quality control and adherence to global medical standards.